United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51672-4130_5356e9be-0f6c-ebbb-e063-6394a90aac4d
- Product NDC
- 51672-4130
- Form
- TABLET
- Composition / generic term
- Lamotrigine
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090127
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (51672-4130-0) / 10 TABLET in 1 BLISTER PACK · 51672-4130-0
- 100 TABLET in 1 BOTTLE (51672-4130-1) · 51672-4130-1
- 1000 TABLET in 1 BOTTLE (51672-4130-3) · 51672-4130-3
- 60 TABLET in 1 BOTTLE (51672-4130-4) · 51672-4130-4
- 30 TABLET in 1 BOTTLE (51672-4130-6) · 51672-4130-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →